Advancing Diagnostics and Therapy to Reach Universal Cure in Childhood ALL.

ABSTRACT: Systemic combination chemotherapy and intrathecal chemotherapy markedly increased the survival rate of children with ALL. In the past two decades, the use of minimal (measurable) residual disease (MRD) measurements early in therapy improved risk group stratification with subsequent treatment intensifications for patients at high risk of relapse, and enabled a reduction of treatment for low-risk patients. The recent development of more sensitive MRD technologies may further affect risk stratification. Molecular genetic profiling has led to the discovery of many new subtypes and their driver genetic alterations. This increased our understanding of the biological basis of ALL, improved risk classification, and enabled implementation of precision medicine. In the past decade, immunotherapies,

SUBMITTER: Pieters R 

PROVIDER: S-EPMC10730082 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature